Bladder Cancer Therapeutics Market Is Anticipated To Register Around 6.4% CAGR From 2022-2031
The Bladder Cancer Therapeutics market is expected to grow significantly in the next decade. The number of new cases diagnosed yearly is expected to increase as the population ages. The most common type of bladder cancer is transitional cell carcinoma, which usually affects the bladder's lining. Treatment options for bladder cancer include surgery, radiation therapy, and chemotherapy. The global bladder cancer therapeutics market is expected to grow from USD 2.6 billion in 2019 to USD 4.4 billion by 2031, at a CAGR of 6.4%. The growth of this market is primarily driven by the rising incidence of bladder cancer and…
- Date: November 17, 2022
- Author: Quintero
- Category: PharmiWeb